All Relations between dopaminergic and Neurodegenerative Diseases

Publication Sentence Publish Date Extraction Date Species
Junming Huang, Bowen Li, Huangwei Wei, Chengxin Li, Chao Liu, Hua Mi, Shaohua Che. Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease. Scientific reports. vol 14. issue 1. 2024-01-25. PMID:38272954. parkinson's disease (pd) is a progressive neurodegenerative disease whose etiology is attributed to development of lewy bodies and degeneration of dopaminergic neurons in the substantia nigra (sn). 2024-01-25 2024-01-28 human
Ramasamy Thangavel, Harleen Kaur, Iuliia Dubova, Govindhasamy Pushphavathi Selvakumar, Mohammad Ejaz Ahmed, Sudhanshu P Raikwar, Raghav Govindarajan, Duraisamy Kempura. Parkinson's Disease Dementia Patients: Expression of Glia Maturation Factor in the Brain. International journal of molecular sciences. vol 25. issue 2. 2024-01-23. PMID:38256254. parkinson's disease (pd) is the second most common progressive neurodegenerative disease characterized by the presence of dopaminergic neuronal loss and motor disorders. 2024-01-23 2024-01-25 human
Hayder M Al-Kuraishy, Sadiq M Al-Hamash, Majid S Jabir, Ali I Al-Gareeb, Ali K Albuhadily, Salim Albukhaty, Ghassan M Sulaima. The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon. Ageing research reviews. 2024-01-18. PMID:38237699. parkinson disease (pd) is a common brain neurodegenerative disease due to progressive degeneration of the dopaminergic neurons in the substantia nigra pars compacta (snpc). 2024-01-18 2024-01-21 Not clear
Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpędek-Kamińska, Ireneusz Majstere. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease. International journal of molecular sciences. vol 25. issue 1. 2024-01-11. PMID:38203531. parkinson's disease (pd) is a complex neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra and the widespread accumulation of alpha-synuclein (αsyn) protein aggregates. 2024-01-11 2024-01-13 Not clear
E R G Plini, M C Melnychuk, A Harkin, M J Dahl, M McAuslan, S Kühn, R T Boyle, R Whelan, R Andrews, S Düzel, J Drewelies, G G Wagner, U Lindenberger, K Norman, I H Robertson, P M Dockre. Dietary Tyrosine Intake (FFQ) Is Associated with Locus Coeruleus, Attention and Grey Matter Maintenance: An MRI Structural Study on 398 Healthy Individuals of the Berlin Aging Study-II. The journal of nutrition, health & aging. vol 27. issue 12. 2023-12-28. PMID:38151868. degradation of the neuromodulatory pathways, (comprising the cholinergic, dopaminergic, serotoninergic and noradrenergic systems) is observed in neurodegenerative diseases and impairs the proper biosynthesis of key neuromodulators from micro-nutrients and amino acids. 2023-12-28 2023-12-30 Not clear
Surabhi Shastry, Junkai Hu, Mingyao Ying, Xiaobo Ma. Cell Therapy for Parkinson's Disease. Pharmaceutics. vol 15. issue 12. 2023-12-23. PMID:38139997. parkinson's disease (pd) is a neurodegenerative disease characterized by the progressive loss of dopaminergic neurons of the substantia nigra pars compacta with a reduction in dopamine concentration in the striatum. 2023-12-23 2023-12-25 Not clear
Myung Ji Kim, Su Hee Cho, Yongbo Seo, Sang-Dae Kim, Hae-Chul Park, Bum-Joon Ki. Neuro-Restorative Effect of Nimodipine and Calcitriol in 1-Methyl 4-Phenyl 1,2,3,6 Tetrahydropyridine-Induced Zebrafish Parkinson's Disease Model. Journal of Korean Neurosurgical Society. 2023-12-22. PMID:38130142. parkinson's disease (pd) is one of the most prevalent neurodegenerative diseases, characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. 2023-12-22 2023-12-24 human
Meng-Fan Yao, Tao Dang, Hua-Jun Wang, Xiao-Zhong Zhu, Chen Qia. Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease. Behavioural brain research. 2023-12-16. PMID:38103871. parkinson's disease (pd) is a neurodegenerative disease characterized by progressive loss of dopaminergic (da) neurons in the substantia nigra pars compacta (snc) and the presence of lewy bodies (lbs) or lewy neurites (lns) which consist of α-synuclein (α-syn) and a complex mix of other biomolecules. 2023-12-16 2023-12-21 human
Andrea Di Credico, Amélie Weiss, Massimo Corsini, Giulia Gaggi, Barbara Ghinassi, Johannes H Wilbertz, Angela Di Baldassarr. Machine learning identifies phenotypic profile alterations of human dopaminergic neurons exposed to bisphenols and perfluoroalkyls. Scientific reports. vol 13. issue 1. 2023-12-11. PMID:38081991. parkinson's disease (pd) is the second most common neurodegenerative disease and is characterized by the loss of midbrain dopaminergic neurons. 2023-12-11 2023-12-17 human
Heba M Mansour, Ahmed F Mohamed, Mahmoud M Khattab, Aiman S El-Khati. Heat Shock Protein 90 in Parkinson's disease: Profile of a serial killer. Neuroscience. 2023-12-01. PMID:38040085. parkinson's disease (pd) is the second most common neurodegenerative disease, characterized by abnormal α-synuclein misfolding and aggregation, mitochondrial dysfunction, oxidative stress, as well as progressive death of dopaminergic neurons in the substantia nigra. 2023-12-01 2023-12-10 Not clear
Lanxin Li, Yang Zhang, Zhengqian Chen, Ruyong Yao, Zhongqiu Xu, Can Xu, Fujie He, Haitao Pei, Cui Ha. SIRT1-dependent mitochondrial biogenesis supports therapeutic effects of vidarabine against rotenone-induced neural cell injury. Heliyon. vol 9. issue 11. 2023-12-01. PMID:38027872. parkinson's disease (pd) is the second most common neurodegenerative disease in the world, which is distinguished by the loss of dopaminergic (da) neurons in the substantia nigra and the formation of intraneuronal. 2023-12-01 2023-12-10 mouse
Haydar M Al-Kuraishy, Ali I Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Mostafa M Bahaa, Aya Talal Zaidalkiani, Ammar Al-Faraga, Gaber El-Saber Batih. Calprotectin in Parkinsonian Disease: Anticipation and Dedication. Ageing research reviews. 2023-11-26. PMID:38008403. parkinson's disease (pd) is a neurodegenerative disease due to degeneration of dopaminergic neurons (dns) in the substantia nigra pars compacta (snpc). 2023-11-26 2023-11-28 Not clear
Min Hyung Seo, Dasom Kwon, Soo-Hwan Kim, Sujung Ye. Association between Decreased SGK1 and Increased Intestinal α-Synuclein in an MPTP Mouse Model of Parkinson's Disease. International journal of molecular sciences. vol 24. issue 22. 2023-11-25. PMID:38003598. parkinson's disease (pd) is a globally common progressive neurodegenerative disease resulting from the loss of dopaminergic neurons in the brain. 2023-11-25 2023-11-28 mouse
Katherine S Morton, Jessica H Hartman, Nathan Heffernan, Ian T Ryde, Isabel W Kenny-Ganzert, Lingfeng Meng, David R Sherwood, Joel N Meye. Chronic high-sugar diet in adulthood protects Caenorhabditis elegans from 6-OHDA-induced dopaminergic neurodegeneration. BMC biology. vol 21. issue 1. 2023-11-11. PMID:37950228. parkinson's disease (pd) is the second most prevalent neurodegenerative disease and is characterized by the progressive death of dopaminergic neurons in the brain. 2023-11-11 2023-11-20 caenorhabditis_elegans
Jeffrey Kim, Etienne W Daadi, Elyas Sebastien Daadi, Thomas Oh, Michela Deleidi, Marcel M Daad. Cells. vol 12. issue 21. 2023-11-10. PMID:37947628. parkinson's disease (pd) is the second most prevalent neurodegenerative disease, characterized by the loss of midbrain dopaminergic neurons which leads to impaired motor and cognitive functions. 2023-11-10 2023-11-20 Not clear
Pragati, Surajit Sarka. Targeted upregulation of dMyc restricts JNK-mediated degeneration of dopaminergic neurons in the paraquat-induced Parkinson's disease model of Drosophila. Neuroscience research. 2023-11-01. PMID:37913999. parkinson's disease is the second most common neurodegenerative disease characterized by the loss of dopaminergic neurons in the brain. 2023-11-01 2023-11-08 human
Bingyun Li, Yujia Jiang, Ting Wang, Weiwei Liu, Xiaojuan Chen, Jinyi He, Zeyu Du, Ruijiao Yang, Danxiu Miao, Yanshu L. MicroRNA-217-5p triggers dopaminergic neuronal degeneration via autophagy activation under Atrazine exposure. Environmental pollution (Barking, Essex : 1987). vol 340. issue Pt 1. 2023-10-31. PMID:37890694. taken together, these results suggest that atr-induced autophagy can accelerate the progression of neurodegenerative diseases and that mir-217-5p is probably an important target involved in atr-induced dopaminergic damage, shedding important light on the development of a novel strategy for treating neurodegenerative diseases. 2023-10-31 2023-11-08 Not clear
Seon-Young Park, HyeJin Yang, Soyoung Kim, Juwon Yang, Hyemin Go, Hyunsu Ba. Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson's Disease Progression in Mice. International journal of molecular sciences. vol 24. issue 20. 2023-10-30. PMID:37894917. parkinson's disease (pd) is a long-term neurodegenerative disease characterized by dopaminergic neuronal loss and the aggregation of alpha-synuclein (α-syn) in the brain. 2023-10-30 2023-11-08 mouse
Su Hyoun Lee, Kwang Chul Chun. USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7. PloS one. vol 18. issue 10. 2023-10-27. PMID:37874827. parkinson's disease (pd) is a common neurodegenerative disease (ndd) characterized by the loss of dopaminergic neurons in the substantia nigra. 2023-10-27 2023-11-08 Not clear
Sazan Ismael, Robert A Colvin, Daewoo Le. Activation of cyclic AMP signaling pathway in dopaminergic neurons rescues locomotion defects in a Drosophila larval model of Parkinson's disease. Brain research. 2023-10-22. PMID:37866407. parkinson's disease (pd) is a neurodegenerative disease showing uncontrollable motor symptoms that are primarily caused by the progressive loss of dopaminergic neurons in the brain. 2023-10-22 2023-11-08 drosophila_melanogaster